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Abstract
The coding sequence of huwentoxin-I, a neurotoxic peptide isolated from the venom of the Chinese spider Ornithoctonus
huwena, was amplified by PCR using the cDNA library constructed from the spider venom glands. The cloned fragment was
inserted into the expression vector pET-40b and transformed into the E. coli strain BL21 (DE3). The expression of a soluble
fusion protein, disulfide interchange protein (DsbC)-huwentoxin-I, was auto-induced in the periplasm of E. coli in the
absence of IPTG. After partial purification using a Ni-NTA column, the expressed fusion protein was digested using
enterokinase to release heteroexpressed huwentoxin-I and was further purified using RP-HPLC. The resulting peptide was
subjected to gel electrophoresis and mass spectrometry analysis. The molecular weight of the heteroexpressed huwentoxin-
I was 3750.69, which is identical to that of the natural form of the peptide isolated from spider venom. The physiological
properties of the heteroexpressed huwentoxin-I were further analyzed using a whole-cell patch clamp assay. The
heteroexpressed huwentoxin-I was able to block currents generated by human Nav1.7 at an IC50 of 640 nmole/L, similar to
that of the natural huwentoxin-I, which is 630 nmole/L.
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Introduction
Huwentoxin-I (HWTX-I) is a neurotoxic peptide isolated from
the venom of the Chinese bird spider Ornithoctonus huwena, which is
distributed in the hilly areas of the provinces of Yunnan and
Guangxi in southern China. The primary structure of HWTX-I
was previously determined. It consists of 33 amino acid residues
and three pairs of disulfide bonds [1,2]. Spatial structure analysis
demonstrated that HWTX-I adopts a compact structure consisting
of a small triple-stranded antiparallel b-sheet stabilized by three
disulfide bonds (Fig. 1) [3]. HWTX-I possesses multiple biological
activities. It reversibly blocks neuromuscular transmission in an
isolated mouse phrenic nerve-diaphragm preparation. It was
demonstrated that HWTX-I is a toxin that blocks N-type voltage-
gated calcium channels (VGCCs) and TTX-S voltage-gated
sodium channels (VGSCs) in adult rat dorsal root ganglion
(DRG) neurons [4,5,6]. It has also been reported that in a rat
formalin test model, the intrathecal administration of HWTX-I is
effective in antinociception [7]. Therefore, HWTX-I has been
considered a model molecule for anti-pain drug development and
is currently in phase I clinical trials.
Although HWTX-I is the most abundant component in
venom (about 15% of the total protein, w/w), isolating HWTX-I
from crude venom using biochemical tools cannot meet the
increasing demands of research due to the limited venom supply
and purification costs. The ultimate solution to this problem
would be the efficient expression of recombinant HWTX-I
(rHWTX-I) in prokaryotic organisms, such as E. coli,o r
eukaryotic systems, such as yeast or cultured cells. In previous
attempts, a synthesized nucleotide fragment was used to express
rHWTX-I fused with either glutathione S-transferase (GST) or
ketosteroid isomerase (KIS) in E. coli cells. The fusion proteins
were expressed in the cytoplasm of E. coli. rHWTX-I released
from the fusion protein demonstrated extremely low bioactivity
before a reduction/renaturation treatment. Although the
reduction/renaturation treatment was able to fully restore the
bioactivities of rHWTX-I, the average yield went down to less
than 50 mg/L [8,9]. Expressing rHWTX-I in the yeast system
Pichia pastoris was also attempted. Four additional amino acid
residues were attached to the N-terminal of the expressed
rHWTX-I, and the bioactivity of the expressed peptide was only
70% in comparison with that of the natural toxin [10]. A
baculovirus system was also used for the expression of rHWTX-
I, but neither the yield nor the cost was satisfactory, despite the
fact that the expressed peptide demonstrated natural bioactivities
[11]. In summary, no efficient system has been developed thus
far to express rHWTX-I in a way that maintains natural
activities with a satisfactory yield.
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21608In this report, we inserted a cDNA copy of HWTX-I into the
pET40b expression vector. rHWTX-I was expressed in fusion
with DsbC in the periplasm of E. coli BL21 (DE3) cells. rHWTX-I
was conveniently purified in a Ni-NTA column and then subjected
to enterokinase digestion. After RP-HPLC purification, the
resulting rHWTX-I demonstrated identical properties to the
natural toxin both biochemically and physiologically.
Materials and Methods
Materials
The E. coli strain Top10F’ used for plasmid cloning was
purchased from Invitrogen (Carlsbad, CA, USA). The expression
vector pET-40b and the E. coli host strain BL21 (DE3) were
purchased from Novagen (Madison, WI, USA). The human
embryonic kidney 293 (HEK293) cell line was purchased from the
Cell Resource Center (Shanghai Institutes for Biological Sciences,
China Academy of Sciences). Enterokinase was purchased from
Majorbio (Shanghai, China). All restriction enzymes and other
enzymes used in molecular cloning experiments were purchased
from Fermentas (Burlington, ON, Canada) if not otherwise
indicated. All chemicals and reagents were purchased from Sigma
(St. Louis, MO, USA). The synthesis of primers and the DNA
sequencing of the constructed plasmids were performed by Sangon
(Shanghai, China). The venom gland cDNA library of the spider
Ornithoctonus huwena was previously constructed and kept in Prof. S.
Liang’s laboratory.
Construction of pET40b-rHWTX-I plasmid
Based on the cDNA sequence of HWTX-I (GenBank Accession
No. AY 263711) [12], two primers were designed to amplify the
coding sequence of HWTX-I. The P-huwen-I-upper primer (59-
CCGGAATTCCGCGTGCAAAGGGGTTTTTGATG-39) con-
tains an EcoR I restriction site (underlined), whereas the P-huwen-
I-lower primer (59-CCGCTCGAGTTATAATTTCCATTTA-
CACCACTTGTG-39) contains a Xho I restriction site (under-
lined). Using the venom gland cDNA library as the template, the
HWTX-I gene was obtained by PCR and inserted between the
EcoR I and Xho I sites present in pET40b. The resulting plasmid
was named pET40b-FrHWTX-I.
In the plasmid pET40b-FrHWTX-I, 45 additional bases were
present between the enterokinase cleavage site and the HWTX-I
gene, which would add 15 extra amino acid residues to the N-
terminal of HWTX-I if expressed. Following a site-directed
deletion mutation procedure described before [13], the additional
bases were eliminated and the resulting plasmid was named
pET40b-rHWTX-I (Fig. 2). The DNA sequences of all construct-
ed plasmids were confirmed by DNA sequencing carried out by
Sangon (Shanghai, China).
Expression and purification of rHWTX-I
The expression vector pET40b-rHWTX-I was transformed into
the E. coli strain BL21 (DE3). Single colonies from the trans-
formants were inoculated in a 5 ml ZYM-505 medium containing
100 mg/ml kanamycin, which was shakenat 200 rpm at 37uC. After
6–8 hours of incubation, the OD600nm of the culture reached about
0.8 (turbid yet not saturated). Then, 400 ml of the culture was
transferred into an 800 ml fresh ZYM-5052 medium (containing
100 mg/ml kanamycin). According to an IPTG-free auto-induction
method of protein expression in the T7 system reported before [14],
the mixture was incubated overnight at 25uC at a shaking rate of
200 rpm. The cells were harvested by centrifugation at 4200 g for
15 min and the supernatant was decanted. After suspending the
cells in sucrose-EDTA solution (30 mM Tris-HCl, pH 8.0, 20%
sucrose, 1 mM EDTA), the periplasmic fractions were prepared by
osmotic shock as previously described [15].
The periplasmic fractions were applied to a gravity Ni-NTA
column, and the eluents were subjected to dialysis to adjust to a
condition suitable for enterokinase digestion. Enterokinase diges-
tion was then performed for 16 hours at 23uC to remove the DsbC
Figure 1. Characterization of HWTX-I. A) Amino acid sequence and disulfide bonds (black lines) of HWTX-I. B) 3D structure of HWTX-I (PDB entry
1qk6). All of the cysteines and disulfide bridges are shown in red. C) Model of the surface calculation of HWTX-I (version 0.99 beta37 by PyMOL).
doi:10.1371/journal.pone.0021608.g001
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for 15 min to remove insoluble particles, and the solution was
subjected to another round of Ni-NTA column purification. The
digested rHWTX-I flowed through the column while DsbC and
enterokinase (which also contained a His-tag) were captured by the
column. The collected flow-through was subjected to RP-HPLC
purification using a C18 column (4.6 mm6250 mm), and a linear
acetonitrile gradient of 25–35% was used for the purification.
Glycine-SDS-PAGE gel electrophoresis
Glycine-SDS-PAGE analysis of the cell lysates, partially purified
proteins, and purified proteins was performed according to the
Laemmli method using 12% acrylamide gels [16].
MALDI-TOF/TOF mass spectrometry
A MALDI TOF/TOF MS spectrometer (Ultraflex
TM, Bruker
Daltonics) was used to determine the molecular mass and purity of
the purified rHWTX-I, according to a method reported previously
[17].
Whole-cell patch-clamp experiments
Whole-cell patch-clamp experiments were carried out according
to a protocol described by Xiao et al. [18]. Briefly, cultured human
embryonic kidney 293 (HEK293) cells were transiently transfected
with a plasmid harboring the cDNA fragment encoding human
Nav1.7 (a subtype of human VGSC a subunits). At 36–72 hours
after the transfection, cells emitting green fluorescence were
selected for whole-cell patch-clamp recordings. Purified rHWTX-I
and natural HWTX-I were dissolved in distilled water to a
concentration of 1 mmole/L and stored at 220uC. Before use, the
stock solution was diluted to the concentrations of interest with
fresh bathing solution. Whole-cell patch-clamp assay recordings
were performed at room temperature using an EPC-9 amplifier
(HEKA, Lambrecht, Germany). Sodium currents were elicited at
210 mV from a holding potential of 280 mM. The recording
and analysis of data were carried out using the Pulse+Pulsefit 8.0
(HEKA, Lambrecht, Germany) and the Sigmaplot 9.0 (Systat
Software Inc.) programs, respectively.
Results
Gene expression and purification of rHWTX-I
The gel electrophoresis analysis of expressed and purified
rHWTX-I is shown in Figure 3. As shown in Figure 3A, compared
with the uninduced cell sample (lane 1), a new band appeared in
the auto-induced cell sample (lane 2); the estimated molecular
weight of this new band was about 34 kDa, which was consistent
with the theoretical molecular weight of the DsbC-HWTX-I
fusion protein. After osmotic shock, the soluble periplasm extracts
(lane 3) were subjected to Ni-NTA column purification, which led
to the partial purification of the 34 kDa product (lane 4). The
semiquantitative SDS PAGE analysis demonstrated that the yield
of the fusion protein was approximately 10 mg/L.
After a dialysis procedure (15 K MWCO), the desalted fusion
proteins were subjected to enterokinase digestion. The digests were
assayed using SDS-PAGE followed by Coomassie Blue staining.
As shown in panel B of Figure 3, enterokinase digestion of the
partially purified fusion protein (lane 7) released two major
products (lane 6). The molecular weights of the resulting products
were 30 kDa and 4 kDa, representing the DsbC protein and free
HWTX-I, respectively.
Figure 2. Construction of the pET40b-rHWTX-I expression vector. A) pET40b-FrHWTX-I. B) pET40b-rHWTX-I.
doi:10.1371/journal.pone.0021608.g002
Figure 3. SDS-PAGE analysis. A) Lane M, protein molecular weight markers; lane 1, uninduced cell sample; line 2, induced cell sample; line3, total
soluble proteins extracted from the periplasm of induced cells; line 4, purified fusion protein (arrow indicates DsbC-rHWTX-I). B) Lane M, protein
molecular weight markers; lane 5, 20 ml DsbC-rHWTX-I after enterokinase digestion; lane 6, 100 ml DsbC-rHWTX-I after enterokinase digestion; line 7,
negative control (10 ml DsbC-rHWTX-I, enterokinase free).
doi:10.1371/journal.pone.0021608.g003
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enterokinase digestion is shown in Figure 4A. Heteroexpressed
rHWTX-I was eluted at an acetonitrile concentration of 30.4%
(upper). A native HWTX-I sample was also loaded into the same
C18 column as a control, although the gradients used were slightly
different; native HWTX-I was eluted at an acetonitrile concen-
tration of 30.6% (lower). Eluted rHWTX-I was collected, vacuum
dried, and subjected to further analysis.
Figure 4B shows the mass spectrometry analysis results of the
RP-HPLC purified product. The molecular mass was determined
to be 3750.69 Da, compared with the theoretical molecular weight
of 3756.45 of native HWTX-I (calculated by adding all 33 amino
acid residues’ mass weights together); a 6-dalton difference
represents the formation of three disulfide bonds by six cysteines.
Based on the mass spectrometry analysis, the overall yield of
purified rHWTX-I was about 0.7 mg/L.
Purified rHWTX-I possesses native electrophyiological
properties of HWTX-I
The electrophysiological properties of purified rHWTX-I were
analyzed using a whole-cell patch-clamp assay. As shown in
Figure 5A, 1 mmole/L of expressed rHWTX-I demonstrated
identical inhibitory activity to that of native HWTX-I at the same
concentration; both of them were able to reduce the hNav1.7
current to 33–36%. The calculated IC50 of rHWTX-I was
640 nmole/L, a value almost identical to that of native HWTX-I,
which was 630 nmole/L (Figure 5B).
Discussion
It has been estimated that there are more than 1 million
currently existing spider species. Based on a conservative estimate,
the potential number of unique spider venom peptides could be
more than 12 million [19]. Spider venoms, as well as venoms from
snakes, frogs, scorpions, sea anemones, and cone snails, have been
widely studied in past decades and have led to the discovery of a
large number of bioactive peptides. The biological diversity of
animal venom peptides refined by the evolutionary process makes
them preoptimized molecules that could be readily used in either
structure/function studies of ion channels/receptors, or the
development of modern drugs.
It was proposed recently that venomics, a high-throughput
approach based on a combination of MS and molecular biology
methods, can be used as a new paradigm for venom exploration
[20]. However, for each and every unique bioactive peptide
identified by venomics or other cutting-edge technologies, a
complete structural/functional characterization is necessary before
it can be used either as a research tool or a drug model molecule.
In these cases, the production of a sufficient quantity of the peptide
remains the greatest bottleneck.
There are three major strategies of venom peptide production:
classical biochemical preparation, direct peptide synthesis, and the
expression of peptide-coding nucleotides. Since most venomous
animals are of very small size, the utilization of bioassay-guided
fractionation technologies is greatly confined due to the limited
amount of venom available. It is also notable that most bioactive
Figure 4. RP-HPLC chromatography and mass spectra of rHWTX-I. A) RP-HPLC chromatography of rHWTX-I (upper) and native HWTX-I
(lower) in the same C18 column. Elution was monitored at 280 nm. rHWTX-I and native HWTX-I were eluted at an acetonitrile concentration of 30.4%
and 30.6%, respectively. B) Mass spectra of purified rHWTX-I. The calculated theoretical molecular weight of rHWTX-I was 3756.45 Da and the
measured molecular weight was 3750.69 Da.
doi:10.1371/journal.pone.0021608.g004
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amino acid residues and are reticulated by several disulfide bridges
[21]. Therefore, the direct synthesis of these peptides is challenged
by not only low efficiency and high cost, but also the oxidative
folding of disulfide-rich peptides.
Various systems were used previously for the recombinant
expression of small peptide toxins with disulfide bridges, including
bacterial systems (mostly E. coli) [8,22,23,24], yeast [25], and
cultured insect cells [26]. Although it is hard to predict which
system is suitable for the expression of a specific bioactive peptide,
the E. coli system, due to its ease of handling and reasonable
product/cost ratio, is always the first choice for most researchers.
As mentioned above, recombinant HWTX-I was expressed in
the cytoplasm of E. coli cells in fusion with GST [8]. Although the
original yield of the fusion protein was more than 10 mg/L
culture, the rHWTX-I released by enzyme digestion exhibited
very low bioactivity. Mass spectrometry analysis demonstrated that
no disulfide bridge formed, yet the formation of the three disulfide
bonds in the natural form is critical to HWTX-I’s functions. It was
reported that the cytoplasm of E. coli cells contains high levels of
reduced glutathione (approximately 5 mmole/L) [27]; therefore,
the potential of the cytoplasm is too reducing for most disulfide
bonds to form. Compared with the cytoplasm, the periplasm of E.
coli cells provides a relatively non-reducing environment that
allows disulfide bridges to form [28]. It was reported that several
peptide toxins, including Dendrotoxin K and Huwentoxin-XI,
were functionally expressed in the periplasm of E. coli with the
formation of disulfide bridges found in their natural forms [29,30].
Compared with other reported procedures for the expression
of disulfide bridge-rich peptides in the periplasm of E. coli,t w o
major improvements were significant in this work. First, DsbC
was used in this system to lead the periplasmic expression of
rHWTX-I. As a disulfide interchange protein, DsbC was
reported to favor the formation of disulfide bridges in their
natural forms [31,32]. Second, instead of the commonly used
IPTG induction protocol, an auto-induction medium was used in
these procedures. Compared with IPTG induction, auto-
induction with lactose does not affect the normal growth of E.
coli cells and induces the expression of a target protein more
gently. In addition, since the transportation of DsbC fusion
protein to the periplasm is mainly controlled by the SecYEG
translocase, the auto-induction procedure effectively precludes
the formation of inclusion bodies that might block the Sec-
dependent pathway [33,34,35,36].
In summary, the procedures reported here provide an efficient
method for the expression of HWTX-I with native bioactivities. It
is expected that this method will be widely used for the expression
of more bioactive peptides with multiple disulfide bridges.
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Figure 5. Effects of rHWTX-I and HWTX-I on wild-type hNav1.7 channels expressed in HEK293 cells. A) Effects of rHWTX-I (left) or native
HWTX-I (right) on currents through hNav1.7 channels that were elicited by depolarization to 210 mV from a holding potential of 2100 mV. The toxin
concentration was 1 mmole/L. B) Effects of rHWTX-I (left) or native HWTX-I (right) on dose-response inhibitory curves of hNav1.7 channels. Data points
shown as mean 6 S.E. (each from three to five experimental cells). The IC50 values of hNav1.7 in response to rHWTX-I and native HWTX-I were
640 nmole/L and 630 nmole/L, respectively.
doi:10.1371/journal.pone.0021608.g005
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